Browsing by Author Stewart, Ralph A.H.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2014Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable AnginaKeech, Anthony (Tony); Mann, Kristy; Simes, Robert John; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Sullivan, David; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAssociation of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable Angina, Journal of the American College of Cardiology, vol.63, 4, 2014,pp 345-354
2013Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyBarnes, Elizabeth; Keech, Anthony (Tony); Marschner, Ian (Colin); Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; Zeller, Tanja; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreChanges in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study, Journal of the American Heart Association, vol.2, 5, 2013,pp 1-12
2003Depression and cardiovascular morbidity and mortality: cause or consequence?Simes, Robert John; Colquhoun, David; North, Fiona M.; Sharples, Katrina J.; Stewart, Ralph A.H.; Tonkin, Andrew M; West, Teena M.; White, Harvey D; School of Public Health: NH&MRC Clinical Trials CentreDepression and cardiovascular morbidity and mortality: cause or consequence?, European Heart Journal, vol.24,(N/A),2003,pp 2027-2037
2016Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID StudyHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Pater, Helen; Simes, Robert John; Sullivan, David; Colquhoun, David; Glasziou, Paul P; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew M; West, Malcolm; White, H D; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study, Circulation, vol.133, 19, 2016,pp 1851-1860
2016Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID StudyHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Pater, Helen; Simes, Robert John; Sullivan, David; Colquhoun, David; Glasziou, Paul P; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew M; West, Malcolm; White, H D; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study, Circulation, vol.133, 19, 2016,pp 1851-1860
2007Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2O'Connell, Rachel; Simes, Robert John; Aylward, Philip E.G.; de Pasquale, Carmen G.; Edmond, John J.; et, al; French, J. K.; Stewart, Ralph A.H.; Van de Werf, Frans J.; van den Berg, K.; Williams, Barbara F.; Wong, C. K.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreVariations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2, European Heart Journal, vol.28,(12),2007,pp 1418-1424